Veritas Capital, Elliott clinch $5.5 billion acquisition of Athenahealth: sources
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/4/2026
- Nasdaq, S&P 500 futures rise ahead of key jobs report
- Oil rallies for the week as U.S.-Iran fighting resumes; diesel hits record high
- BofA's Hartnett says stay long commodities and gold as 'policy panic' works
- TikTok owner ByteDance said to secure $29.6bn loan for AI push
- Fed’s Waller open to September rate hold - if disinflation holds up
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
- After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
- After-Hours Movers: NVDA, CRM, SNPS, CRWD, OKTA, NTNX
General Electric (GE) PT Lowered to $10 at Gordon Haskett
November 13, 2018 9:20 AM ESTGordon Haskett analyst John Inch lowered the price target on General Electric (NYSE: GE) to $10.00 (from $11.00) while maintaining an Underperform rating. While GE has provided assurances that it retains plenty of opportunities through asset sales, Inch's calculations indicate most of these proceeds are already... More
General Electric (GE) PT Lowered to $10 at Credit Suisse
November 12, 2018 8:54 AM ESTCredit Suisse analyst, John Walsh, lowered the price target on General Electric (NYSE: GE) to $10.00 (from $12.00) while maintaining a Neutral rating. GE has declined 15% versus the XLI up 4% and the S&P 500 up 3%. Fallout from yield investors is adding pressure.
Investors are focused... More
athenahealth (ATHN) PT Lowered to $142 at KeyBanc Following 3Q
November 12, 2018 7:52 AM ESTKeyBanc analyst Donald Hooker lowered the price target on athenahealth (NASDAQ: ATHN) to $142.00 (from $170.00) while maintaining a Overweight rating following the company's 3Q. ATHN reported weak 3Q18 top-line metrics with soft bookings of only $38M (down ~34% y/y) and revenues lagging consensus ($330M vs.... More
Baird Downgrades athenahealth (ATHN) to Neutral Following Takeout Bid
November 12, 2018 4:21 AM ESTBaird analyst Matthew Gillmor downgraded athenahealth (NASDAQ: ATHN) from Outperform to Neutral with a price target of $135.00 (from $160.00).
The analyst steps aside following the expected takeout from Veritas and Elliot. He is not expecting a competing bid to emerge.
For an analyst... More
